Glomerulonephritis Flashcards

1
Q

What is glomerulonephritis?

A

Immune-mediated disease of the kidneys affecting the glomeruli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How can glomerulonephritis be classified?

A
  • Aetiology (Primary vs secondary)
  • Histopathology
  • Clinical syndromes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some primary syndromes of glomerulonephritis?

A
  • Minimal change disease
  • Focal segmental glomerulosclerosis
  • Membranous nephropathy
  • Membrano-proliferative glomerulonephritis
  • IgA nephropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some secondary causes of glomerulonephritis?

A

Goodpasture’s disease
Circulating immune complexes
Vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some causes of circulating immune complexes causing glomerulonephritis?

A

Infection
Drugs
Cancer - Lymphomas
SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some forms of infective causes of glomerulonephritis?

A

Hepatitis
Bacteria - Post-streptococcal GN
HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does post-streptococcal GN present?

A

GN symptoms occurring around 2 weeks after streptococcal infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some drugs that can cause glomerulonephritis?

A

Gold
Penicillamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some histological classes of glomerulonephritis?

A

Proliferative vs non-proliferative
Focal vs diffuse
Global vs segmental
Cresentic?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is meant by proliferative GN?

A

GN with presence of proliferation of mesangial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is meant by non-proliferative GN?

A

GN without presence of proliferation of mesangial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is meant by focal GN?

A

GN in which < 50% of glomeruli are affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is meant by diffuse GN?

A

GN in which > 50% of glomeruli are affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is meant by global GN?

A

GN in which all of the glomerulus is affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is meant by segmental GN?

A

GN in which only part of the glomerulus is affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is meant by crescentic GN?

A

GN in which there are crescents:
- Epithelial cell extra-capillary proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some clinical syndromes of GN?

A

Nephritic syndrome
Nephrotic syndrome
Rapidly progressive glomerulonephritis
Asymptomatic haematuria or proteinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are some ways in which the humeral immune system can lead to glomerulonephritis

A

Ig’s against normal glomerular constituents
Ig’s against non-self antigens
Deposition of immune complexes
Complement activation and inflammatory mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What conditions can cause Ig’s against normal glomerular constituents?

A

Goodpasture’s disease
Membranous nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What conditions can cause Ig’s against non-self antigens in GN?

A

ANCA
IgA nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What conditions can cause deposition of circulating immune complexes in GN?

A

Post-infectious GN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What conditions cause complement activation and inflammatory mediator release in GN?

A
  • C3 glomerulopathy
  • Post-infectious glomerulonephritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are some conditions that cause cell-mediated immune response in GN, resulting in cytokine and GF release from T-cells and macrophages?

A
  • Focal segmental glomerulosclerosis
  • Crescentic glomerulonephritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What results from mesangial damage in GN?

A

Inflammation within the mesangium results in proliferation and Ang2 and chemokine release
This causes proliferative lesion formation and attraction of inflammatory cells
This causes endothelial damage and therefore RBC leakage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What results from podocyte damage in GN?

A

Podocyte damage causes podocyte atrophy, casing loss of size/charge specific barrier
This leads to a non-proliferative lesion and protein leakage (Proteinuria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is rapidly progressive glomerulonephritis?

A

This is the immune mediated rapid loss of renal function over days, weeks or a few months, presenting with severe nephritic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What investigations are required in RPGN?

A

Kidney biopsy
Serological testing
Early!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Describe the histology of RPGN

A

Crescent formation on renal biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are some ANCA +ve causes of RPGN?

A
  • Granulomatosis with polyangiitis (GPA)
  • Microscopic polyangiitis (MPA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are some ANCA -ve causes of RPGN?

A
  • Goodpasture’s disease
  • Henoch-Schonlein purpura
  • Systemic lupus erythematosus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are some important history points in GN history taking?

A
  • Foamy or frothy urine?
  • Rashes/Eye symptoms/Respiratory symptoms
  • Recent infections
  • Family history
  • Medication or drug use
31
Q

What are some possible examinations findings in GN?

A
  • Oedema - Periorbital oedema in the morning
  • Huekrcke lines in nails
  • Xanthelasma
  • Rashes - Petechial or purpuric
  • Synovitis
  • Hypertension
32
Q

What tests are required in GN?

A

Bloods
Urine investigations
Kidney USS
Renal biopsy

33
Q

What bloods are required in GN?

A

U+E (AKI or CKD)
Immunological testing (E.g. ANCA, Anti-GBM)

34
Q

What urine investigations are required in GN?

A

Urinalysis (Haematuria, proteinuria)
Urine microscopy
Urine Protein:Creatinine (PCR) on 24-hour urine

35
Q

What are the 4 main stages of proteinuria?

A

Microalbuminuria (30-300mg/day)
Asymptomatic proteinuria (<1g/day)
Heavy proteinuria (1-3g/day)
Nephrotic syndrome (>3g/day)

36
Q

What may be seen on urine microscopy in GN?

A

Dysmorphic RBCs
RBC casts
Granular casts
Lipiduria

37
Q

What may be seen on kidney USS in GN?

A

Small kidneys
Severe cortical thinning

38
Q

What are the 3 main tests which may be performed on a renal biopsy sample?

A

Light microscopy
Electron microscopy
Immunofluorescence

39
Q

What may be seen on light microscopy in GN?

A

Hypercellularity - Inflammatory and reactive proliferations
Sclerosis
Crescents (In RPGN)
Granulomas (In GPA and Sarcoid)

40
Q

What may be seen on electron microscopy in GN?

A

Immune complex depositions in the basement membran e

41
Q

What may be shown on immunofluorescence in GN?

A

Antibody type and distribution

42
Q

What will be seen on immunofluorescence in Goodpasture’s GN?

A

Linear IgG in basement membrane

43
Q

What are the aims of treatment in GN?

A

Reduce proteinuria, induce remission of nephrotic syndrome and preserve long-term renal function

44
Q

What is meant by complete remission of nephrotic syndrome?

A

Proteinuria < 300mg/day

45
Q

What is meant by partial remission of nephrotic syndrome?

A

Proteinuria < 3-3.5g/day

46
Q

What are some non-immunosuppressive management options for GN?

A
  • Anti-hypertensives (ACEi/ARB)
  • Diuretics
  • Statins
  • Anticoagulation (Nephrotic syndrome with hypoalbuminaemia)
  • Salt and fluid restriction (Nephrotic syndrome)
47
Q

What are some immunosuppressive drugs used to manage GN?

A

Corticosteroids
Alkylating agents
Calcineurin inhibitors
Anti-proliferative

48
Q

What are some examples of alkylating agents?

A

Cyclophosphamide
Chlorambucil

49
Q

What are some examples of calcineurin inhibitors?

A

Cyclosporin
Tacrolimus

50
Q

What are some examples of anti-proliferative drugs?

A

Azathioprine
Mycophenolate Mofentil

51
Q

What are some forms of immunosuppressive treatments of GN?

A

Drugs
Pasmapharesis
Antibodies (IV Ig)

52
Q

Management of RPGN

A

Strong immunosuppressives
Dialysis

53
Q

What is the most common form of GN in children?

A

Minimal change disease

54
Q

What is the possible pathology of minimal change disease?

A

Unknown cause, however, there is thought to be some involvement of B-cells and anti-nephron antibodies

55
Q

Histology of minimal change disease

A

Characteristic diffuse effacement of the podocyte foot processes on electron microscopy

Normal on LM and IF

56
Q

Treatment of minimal change disease

A
  • 1st line - Oral corticosteroids
  • 2nd line - Cyclophosphamide/Rituximab
57
Q

What is focal segmental glomerulosclerosis?

A

This is a histological lesion rather than a disease and is the 2nd most common cause for nephrotic syndrome in adults

58
Q

Primary cause of focal segmental glomerulosclerosis

A

General podocyte dysfunction

59
Q

Secondary causes of focal segmental glomerulosclerosis

A
  • HIV
  • Drugs - pamidronate, interferon, heroin and obesity
60
Q

Histology of focal segmental glomerulosclerosis

A

Sclerosis in parts of some glomeruli on LM
No immune deposits or foot process effacement

61
Q

Treatment of focal segmental glomerulosclerosis

A
  • 1st line - High dose glucocorticosteroids
  • 2nd line - CNIs - Calcineurin inhibitors (E.g. tacrolimus)
62
Q

Prognosis of focal segmental glomerulosclerosis

A

50% will progress to ESRF after 10 years

63
Q

What is membranous nephropathy

A

This is another pattern of injury found on histology, instead of a disease and is the commonest cause of nephrotic syndrome in adults

64
Q

Primary cause of membranous nephropathy

A

Anti-PLA2R antibodies

65
Q

Secondary causes of membranous nephropathy

A
  • Infection - HepB, Parasites
  • Connective tissue disease - Lupus
  • Malignancy - Carcinomas, Lymphomas
  • Drugs - Gold, Penicillamine
66
Q

Histology of membranous nephropathy

A
  • Thickening of GBM on LM
  • Spike and dome pattern with silver staining on LM
  • Subepithelial immune complex deposition in the GBM on EM
67
Q

Treatment of membranous nephropathy

A

immunosuppression - Cyclophosphamide

68
Q

What is membranoproliferative GN

A

MPGN is a histologic lesion and not a specific disease entity

It’s pattern of injury once identified will require further evaluation to find underlying causes.

69
Q

What are the 2 primary mechanisms of MPGN?

A
  • Immune complex deposition and activation of complement
  • Complement dysregulation leading to persistent activation of alternative pathway
70
Q

Histology of MPGN

A
  • Thick capillary wall
  • Glomerular membrane proliferation
  • Immunofluorescent microscopy shows immune complex deposition in capillary walls
71
Q

Treatment of MPGN

A
  • Treating underlying infections etc (Hep C)
  • Immunosuppression with steroids/ MMF for idiopathic cases
  • Complement inhibitors such as eculizumab for disregulation
72
Q

What is the most common form of GN in adults in the world?

A

IgA nephropathy (Berger’s disease)

73
Q

How will IgA nephropathy usually present?

A
  • 10-20 years old
  • Asymptomatic microhaematuria ± Non-nephrotic range proteinuria
  • Macroscopic haematuria post-infection
  • AKI/CKD
74
Q

What causes IgA nephropathy?

A

This can be caused by respiratory or GI infection and there is an association with Henoch-Schönlein purpura

75
Q

Histology of IgA nephropathy

A
  • Mesangial cell proliferation and expansion on light microscopy
  • IgA deposits in mesangium on immunofluorescence
76
Q

Treatment of IgA nephropathy

A
  • SGLT2 inhibitors
  • Budesonide
  • Dual endothelin-angiotensin receptor antagonist (Sparsentan)